IR CANCELLED; US REGISTRATION CANCELLED
on 19 Jun 2020
Last Applicant/ Owned by
3rd Floor 20 Primrose Street
London EC2A 2RS
GB
Serial Number
79087264 filed on 19th Jun 2010
Registration Number
3922328 registered on 22nd Feb 2011
Filing Basis
No Filing Basis
Disclaimer
NO DATA
RENAPEP
Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke
Mark Details
Serial Number
No 79087264
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 10th Jul 2021 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED |
| 10th Jul 2021 | DEATH OF INTERNATIONAL REGISTRATION |
| 14th Sep 2018 | TOTAL INVALIDATION PROCESSED BY THE IB |
| 07th Jun 2018 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| 07th Jun 2018 | INVALIDATION PROCESSED |
| 29th May 2018 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 29th Sep 2017 | CANCELLED SECTION 71 |
| 04th Aug 2016 | NEW REPRESENTATIVE AT IB RECEIVED |
| 22nd Feb 2016 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| 11th Oct 2013 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |